Navigation Links
China Medicine Releases White Paper on Developing Recombinant Aflatoxin-Detoxifizyme
Date:7/9/2008

GUANGZHOU, China, July 9 /Xinhua-PRNewswire/ -- China Medicine Corporation (OTC Bulletin Board: CHME; " China Medicine" or " the Company"), a leading distributor and developer of ethical and over-the-counter drugs, traditional Chinese Medicine (TCM), nutritional and dietary supplements, medical devices, and medical formulations in the People's Republic of China (PRC), announced today that it released a white paper on Recombinant Aflatoxin-Detoxifizyme ("rADTZ"). The paper describes the origin, development and history of rADTZ, its scientific basis, and its market potential in the feed, food and health care industries. The white paper is available for download on the Company's website: http://www.chinamedicinecorp.com/adtz.htm .

"We are very excited about the development of rADTZ, which has the potential to detoxify aflatoxin (AFT) in food and feed, and we are currently carrying out experiments on animal feed," said Mr. Senshan Yang, Chairman and CEO of China Medicine Corporation. "We hope to bring you positive news on the results in the near future."

About China Medicine Corporation

China Medicine Corporation is a leading pharmaceutical company which discovers and develops medical formulations and distributes over 2,200 pharmaceutical products in China including prescription and over-the-counter drugs, traditional Chinese medicine products, herbs and dietary supplements. The Company distributes the products to wholesale distributors in 28 provinces and to more than 300 hospitals, 500 medicine companies, and 1,788 drug stores throughout China. The Company actively develops a number of proprietary products for many uses including oncology, high blood pressure and the removal of toxins from food and animal feeds. For more information visit the Company's website at http://www.chinamedicinecorp.com .

Cautionary Statement

This press release contains forward-looking statements concerning the Company's business and products. The Company's actual results may differ materially depending on a number of risk factors including, but not limited to, the following: general economic and business conditions, obtaining regulatory approval for new products, the expected contribution of higher margin products, government support for rural health care, competition from existing and new competitors, changes in technology, and various other factors beyond its control. All forward-looking statements are expressly qualified in their entirety by this Cautionary Statement and the risk factors detailed in the Company's reports filed with the Securities and Exchange Commission. China Medicine Corporation undertakes no duty to revise or update any forward-looking statement to reflect events or circumstances after the date of this release.

Company Contact:

Ms. Huizhen Yu

Chief Financial Officer

China Medicine Corp.

Tel: +86-20-8739-1718

Email: konzern08@163.com

Web: http://www.chinamedicinecorp.com

Investor Relations Contact:

Mr. Crocker Coulson, President

CCG Elite Investor Relations

Tel: +1-646-213-1915

Email: crocker.coulson@ccgir.com

Mr. Richard Micchelli, Financial Writer

CCG Elite Investor Relations

Tel: +1-646-454-4516

Email: richard.micchelli@ccgir.com

Web: http://www.ccgelite.com


'/>"/>
SOURCE China Medicine Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Chindex International, Inc. Announces Receipt of Key Regulatory ApprovalsChina SFDA Certificates Received Include Intuitive Surgical daVinci S
2. China Improves Safety Management on Imported Foods in Preparation for Olympic Games
3. AMDL Signs Letter of Intent to Purchase China-Based Pharmaceutical Distribution Company
4. Cynosure Expands Presence in China with the Opening of Sales Office in Beijing
5. Golden Meditech Pioneers into Chinas Hospital Market
6. Chinas Leading Healthcare Market Player Records 200% Increase in Profits and Earnings
7. Thomson Reuters Introduces a New Solution to Boost Competitive Advantage in Chinas Generics and API Market
8. China Medicine Maintains Exclusive Rights to Distribute 2,300 Pharmaceutical Products
9. China Sky One Medical, Inc. Research Center Recognized by Heilongjiang Science and Technology Institute
10. China Yingxia International, Inc. Appoints Chief Financial Officer
11. China Sky One Medical, Inc. to Acquire Peng Lai Jin Chuang Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... Pro3rd Grunge is a package of ... lower thirds to introduce people, characters, and locations without having to set a single ... textures and many more design components. Simply select a preset and drag it into ...
(Date:4/29/2016)... ... April 29, 2016 , ... The number of chronically and seriously ill individuals ... there is an urgent need for highly skilled care managers and care coordinators. ... approach to train and retain care managers, and enhance their skills. , ...
(Date:4/29/2016)... ... 2016 , ... Orthodontics Limited, one of the nation’s top ... Middleberg, were asked by Invisalign to present an “Ask the Expert” ... “Advancing the Biomechanics of Invisalign Clear Aligners,” Dr. Gemmi and Dr. Middleberg demonstrated ...
(Date:4/28/2016)... ... ... Beauty® is offering a special deal on its webstore. , Buy 1 product and get ... the product with lesser value. In addition, a free bonus of 3 top serums ... , "So many women (men, too) love our products and get good results. We want ...
(Date:4/28/2016)... ... April 28, 2016 , ... Sanford Health’s work in cellular ... of researchers and leaders from Sanford Health were selected to participate in the ... Impact ” and receive the 2016 Pontifical Key Innovation Award at the Vatican. ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... 2016 Global  urinalysis market ... by 2022, according to a new report by ... http://photos.prnewswire.com/prnh/20150105/723757 ) , Automation ... and accuracy delivered by the new generation urinalysis ... urinalysis instruments and consumables. For instance, the automatic ...
(Date:4/26/2016)... Diplomat Pharmacy, Inc. (NYSE: DPLO) is pleased ... Pharm D., to Vice President of Education and Quality. ... will continue to lead and oversee Diplomat University, an ... and training to Diplomat employees and external professionals on ... also houses the quality assurance department, which focuses on ...
(Date:4/26/2016)... -- Research and Markets has announced the ... report to their offering.      (Logo: ... market is projected to grow at a CAGR of ... is a technique that involves measurement and analysis of ... changes in biochemical pathways. The aim of performing these ...
Breaking Medicine Technology: